Delivery Order SPE2DB20D3101-SPE2DB25FRTY4
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,843.69 for Rotarix vaccine oral syringes (1.5 mL) with a completion date of July 30, 2025. This competitive award, issued on July 29, 2025, carries firm fixed-price terms and involves no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $31.3K firm fixed price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ml) with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order was performed at...
- The Defense Logistics Agency awarded a delivery order valued at $6,644.97 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 milliliter units). This firm fixed-price delivery order, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $26,579.88 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price contract represents a small component of the vendor's extensive pharmaceutical supply operations supporting federal medical procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,953.32 delivery order to AmerisourceBergen Drug Corp for ROTARIX Vaccine Oral Syringe 1.5ML, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's existing pharmaceutical supply framework...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe format (1.5mL) under a firm fixed-price contract valued at $7,636.40. The contract was competitively awarded without set-aside restrictions and carries an ultimate completion date of July 1, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a continuation of the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Rotarix vaccine oral syringes (1.5mL) with a ceiling value of $12,644.74. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,696.28 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Rotarix vaccine oral syringes in 1.5ml quantities. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and was competitively awarded with no set-aside designation. This award represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,429.98 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ML) on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-set-aside, firm fixed price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,067.22 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine oral syringes (1.5mL) with a firm fixed price structure. The contract, which was competitively awarded with no set-aside designation, is scheduled for ultimate completion on April 25, 2025, one day after the award date of April 24, 2025. Performance will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania. This...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRTY4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,953.40 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe 1.5ml format. This firm fixed-price contract, with an ultimate completion date of September 2, 2025, was competitively awarded without set-aside designation. The performance location is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single procurement action under AmerisourceBergen's existing contract vehicle with the Defense Logistics Agency. This award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The prime contract, designated SPE2DX, enables the company to supply a wide range of pharmaceutical products, vaccines, and medical supplies to support Defense Health Agency and other federal healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability to fulfill federal medical procurement requirements through its established track record of competitively awarded contracts across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 8/29/25 |